XML 58 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets (Tables)
6 Months Ended
Oct. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the Carrying Amount of Goodwill
The following table presents the changes in the carrying amount of goodwill by segment:
(in millions)Cardiac and Vascular GroupMinimally Invasive Therapies GroupRestorative Therapies GroupDiabetes GroupTotal
April 24, 2020$6,831 $20,176 $10,920 $1,914 $39,841 
Goodwill as a result of acquisitions— — 35 346 381 
Purchase accounting adjustments— — — 
Currency translation and other95 772 119 987 
October 30, 2020$6,926 $20,948 $11,077 $2,261 $41,212 
Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
October 30, 2020April 24, 2020
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$17,017 $(5,567)$16,963 $(5,065)
Purchased technology and patents11,041 (4,767)10,742 (4,354)
Trademarks and tradenames469 (241)464 (232)
Other78 (58)75 (53)
Total$28,605 $(10,633)$28,244 $(9,704)
Indefinite-lived:
IPR&D$440 $— $523 $— 
Gross Carrying Amount of Indefinite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
October 30, 2020April 24, 2020
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$17,017 $(5,567)$16,963 $(5,065)
Purchased technology and patents11,041 (4,767)10,742 (4,354)
Trademarks and tradenames469 (241)464 (232)
Other78 (58)75 (53)
Total$28,605 $(10,633)$28,244 $(9,704)
Indefinite-lived:
IPR&D$440 $— $523 $— 
Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October 30, 2020, excluding any possible future amortization associated with acquired IPR&D which has not yet met technological feasibility, is as follows:
(in millions)Amortization Expense
Remaining 2021$888 
20221,738 
20231,674 
20241,643 
20251,617 
20261,604